MabSpace and HJB have formed a new biotherapeutics organization dubbed Transcenta Holding.

A political deadlock that led to a partial government shutdown before Christmas could take some of the shine off a golden year of FDA approvals.

WuXi AppTec shares firm some a week after the company debuted its IPO on the Hong Kong exchange.

Pharmaceutical Product Development is adding more punch to its therapeutics offerings with new leadership.

Target PharmaSolutions announced a pair of partnerships that includes Gilead and Bristol-Myers Squibb.

TrialSpark launches its first clinical trial sites as part of a partnership with Novartis that takes a new direction.

Parexel partnering with Eli Lilly to support building a clinical trial learning and development program in China.

The acquisition is expected to bolster Biotage’s presence as a separations company within the growing biomolecule arena.